ethyl 4-(2,5-dimethylphenyl)-2-hydroxy-4-oxobut-2-enoate, 95%, 1g

1,4-Cyclohexanedimethanol Bis(2-ethylhexanoate) (cis- and trans- mixture)>98.0%(GC)25g

(S)-Oxiran-2-ylmethyl 4-nitrobenzenesulfonate, 98%, 1g

EWF 10x/22 mm eyepiece with crosshair, Ø 30 mm tube

(3R)-(+)-3-(Ethylamino)pyrrolidine>97.0%(GC)(T)1g

(S)-3-tert-Butoxycarbonylamino-4-methyl-pentanoic acid, 99.0%, 5g

(R)-2-METHYLBUTANE-2-SULFINAMIDE, 97.0%, 1g

(2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 98%, 500mg

Filtration unit Rapid-Flow with PES membrane Pore size 0.45 μm, 500 ml, 500 ml, 90 mm, 12 Piece(s)

FENOXAZOLINE, 95.0%, 500mg

8-bromoimidazo[1,2-a]pyridin-3-amine, 95.0%, 250mg

Fmoc-Ala-Ala-OH, 98.0%, 25g

Morpholine-2-carboxamide, 97%, 1g